Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Iradimed Corp Company Profile (NASDAQ:IRMD)

Consensus Ratings for Iradimed Corp (NASDAQ:IRMD) (?)
Ratings Breakdown: 1 Buy Rating(s), 1 Strong Buy Rating(s)
Consensus Rating:Strong Buy (Score: 3.50)
Consensus Price Target: $18.00 (5.16% downside)

Analysts' Ratings History for Iradimed Corp (NASDAQ:IRMD)
Show:
DateFirmActionRatingPrice TargetActions
5/4/2015ZacksUpgradeHold -> Strong-Buy$18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/28/2015Roth CapitalSet Price TargetBuy$18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/6/2015Roth CapitalSet Price TargetBuy$15.00 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/23/2014Roth CapitalBoost Price TargetBuy$12.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/11/2014Roth CapitalInitiated CoverageBuy$14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/25/2013 forward)